-Sharon Marsh Researcher Activity Profile

Research Author Detailed Information 

Sharon Marsh Publication Rate By Year

Sharon Marsh has published 1 paper(s) in 1997, 1 paper(s) in 2004, 1 paper(s) in 2005, 5 paper(s) in 2006, 15 paper(s) in 2007, 4 paper(s) in 2008, for a total of 27 research publications in total.

Sharon S Marsh Author Information

LAST NAME: marsh

FIRST NAME: Sharon

INITIALS: s

AFFILIATION:

Papers

Sharon Marsh's Publication Record

1. A phase II study of irinotecan and carboplatin in advanced non-small cell lung cancer with pharmacogenomic analysis: final report. Year Published: 2007
Division of Medical Oncology, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
2. Genetic variation in the B-type natiuretic peptide pathway affects BNP levels. Year Published: 2007
Section of Advanced Heart Failure and Cardiac Transplantation, Henry Ford Heart and Vascular Institute, Henry Ford Hospital, 2799 W. Grand Boulevard, Cardiology K14, Detroit, MI 48202, USA. dlanfea1@hfhs.org
3. Identification of NR1I2 genetic variation using resequencing. Year Published: 2007
Department of Medicine, Washington University School of Medicine, St. Louis, MO, 63110, USA.
4. CEPH individuals are representative of the European American population: implications for pharmacogenetics. Year Published: 2005
Washington University School of Medicine, Department of Medicine, St. Louis, MO, USA.
5. ABCB1 2677G>T/A genotype and paclitaxel pharmacogenetics in ovarian cancer. Year Published: 2006
6. DNA repair pathway profiling and microsatellite instability in colorectal cancer. Year Published: 2006
Department of Medicine, Washington University School of Medicine and Siteman Cancer Center, Saint Louis, Missouri 63110-1093, USA.
7. Irinotecan-induced diarrhea: functional significance of the polymorphic ABCC2 transporter protein. Year Published: 2006
Department of Medical Oncology, Erasmus University Medical Center, Daniel den Hoed Cancer Center, Rotterdam, The Netherlands.
8. Variants in the SLCO1B3 gene: interethnic distribution and association with paclitaxel pharmacokinetics. Year Published: 2006
Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.
9. Pyrosequencing applications. Year Published: 2006
Division of Oncology, Washington University School of Medicine, St. Louis, MO, USA.
10. Pharmacogenetics and oncology treatment for breast cancer. Year Published: 2007
Washington University School of Medicine, Division of Oncology, St Louis, MO 63110, USA. smarsh@im.wustl.edu
11. Impact of pharmacogenomics on clinical practice in oncology. Year Published: 2007
Division of Oncology, Washington University School of Medicine, St Louis, Missouri 63110, USA. smarsh@im.wustl.edu
12. Pharmacogenetic assessment of toxicity and outcome after platinum plus taxane chemotherapy in ovarian cancer: the Scottish Randomised Trial in Ovarian Cancer. Year Published: 2007
Washington University School of Medicine, Division of Oncology, St Louis, MO 63110, USA. smarsh@im.wustl.edu
13. Pharmacogenomics. Year Published: 2007
Washington University, Division of Molecular Oncology, St Louis, USA.
14. Connexin37 (GJA4) genotype predicts survival after an acute coronary syndrome. Year Published: 2007
Henry Ford Heart and Vascular Institute and Wayne State University, Detroit, MI, USA.
15. Pharmacogenetic analysis of paclitaxel transport and metabolism genes in breast cancer. Year Published: 2007
Department of Medicine, Washington University School of Medicine, St Louis, MO 63110, USA. smarsh@im.wustl.edu
16. Physiological associations of computerized tomography lung density: a factor analysis. Year Published: 2007
Medical Research Institute of New Zealand, Wellington.
17. Pharmacogenetic assessment of toxicity and outcome after platinum plus taxane chemotherapy in ovarian cancer: the Scottish Randomised Trial in Ovarian Cancer. Year Published: 2007
Washington University School of Medicine, Division of Oncology, St Louis, MO 63110, USA. smarsh@im.wustl.edu
18. Recommendations for locus-specific databases and their curation. Year Published: 2007
Genomic Disorders Research Centre, St. Vincent's Hospital Melbourne, Australia.
19. Recommendations for locus-specific databases and their curation. Year Published: 2007
Genomic Disorders Research Centre, St. Vincent's Hospital Melbourne, Australia. cotton@unimelb.edu.au
20. Recommendations for locus-specific databases and their curation. Year Published: 2007
Genomic Disorders Research Centre, St. Vincent's Hospital Melbourne, Australia. cotton@unimelb.edu.au
21. Current concepts in the development of heterotopic ossification. Year Published: 2004
Department of Trauma, Hannover Medical School, Unfallchirurgische Klinic, Hannover 305625, Germany.
22. Physiological associations of computerized tomography lung density: a factor analysis. Year Published: 2007
Medical Research Institute of New Zealand, Wellington.
23. Germline polymorphisms in EGFR and survival in patients with lung cancer receiving gefitinib. Year Published: 2008
Department of Oncology, Scientific Institute University Hospital San Raffaele, Milan, Italy.
24. Cancer pharmacogenetics. Year Published: 2008
Division of Oncology, Washington University School of Medicine, St. Louis, Missouri, USA.
25. An integrated YAC map of the human X chromosome. Year Published: 1997
26. Pharmacogenetics: global clinical markers. Year Published: 2008
Washington University School of Medicine, Campus Box 8069, 660 S. Euclid Ave., St. Louis, MO 63110, USA. smarsh@im.wustl.edu.
27. Pharmacogenetics: global clinical markers. Year Published: 2008